Research ArticleNuclear Oncology
Comparison of Copper-67- and Iodine-125-Labeled Anti-CEA Monoclonal Antibody Biodistribution in Patients with Colorectal Tumors
Angelika Bischof Delaloye, Bernard Delaloye, Franz Buchegger, Charles-André Vogel, Michel Gillet, Jean-Pierre Mach, Alan Smith and P. August Schubiger
Journal of Nuclear Medicine June 1997, 38 (6) 847-853;
Angelika Bischof Delaloye
Bernard Delaloye
Franz Buchegger
Charles-André Vogel
Michel Gillet
Jean-Pierre Mach
Alan Smith
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Comparison of Copper-67- and Iodine-125-Labeled Anti-CEA Monoclonal Antibody Biodistribution in Patients with Colorectal Tumors
Angelika Bischof Delaloye, Bernard Delaloye, Franz Buchegger, Charles-André Vogel, Michel Gillet, Jean-Pierre Mach, Alan Smith, P. August Schubiger
Journal of Nuclear Medicine Jun 1997, 38 (6) 847-853;
Comparison of Copper-67- and Iodine-125-Labeled Anti-CEA Monoclonal Antibody Biodistribution in Patients with Colorectal Tumors
Angelika Bischof Delaloye, Bernard Delaloye, Franz Buchegger, Charles-André Vogel, Michel Gillet, Jean-Pierre Mach, Alan Smith, P. August Schubiger
Journal of Nuclear Medicine Jun 1997, 38 (6) 847-853;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Peptide Receptor Radionuclide Therapy with 67Cu-CuSarTATE Is Highly Efficacious Against a Somatostatin-Positive Neuroendocrine Tumor Model
- Therapeutic Radiometals Beyond 177Lu and 90Y: Production and Application of Promising {alpha}-Particle, {beta}--Particle, and Auger Electron Emitters
- In vivo Evaluation of 177Lu- and 67/64Cu-Labeled Recombinant Fragments of Antibody chCE7 for Radioimmunotherapy and PET Imaging of L1-CAM-Positive Tumors
- 67Cu- versus131I-Labeled Lym-1 Antibody: Comparative Pharmacokinetics and Dosimetry in Patients with Non-Hodgkin's Lymphoma